Milan, Italy

Pietro Cazzulani


Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 30(Granted Patents)


Location History:

  • Casal Pusterlengo, IT (1985)
  • Milan, IT (1984 - 1989)

Company Filing History:


Years Active: 1984-1989

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Work of Pietro Cazzulani

Introduction

Pietro Cazzulani, an accomplished inventor based in Milan, Italy, has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Cazzulani has focused his research on developing therapeutically active compounds aimed at treating various medical conditions.

Latest Patents

Cazzulani's latest innovations include two notable patents:

1. **Therapeutically Active Flavonyl-1,4-Dihydropyridines:** This patent describes novel flavonyl-1,4-dihydropyridines, which have been identified as effective calcium antagonists and smooth muscle relaxants.

2. **Antianaphylactic and Antibronchospastic Piperazinyl Compounds:** This invention involves new piperazine derivatives that function as therapeutically useful antianaphylactic and antibronchospastic agents. These compounds include variations in their chemical structure, enhancing their efficacy.

Career Highlights

Throughout his career, Pietro has held positions at Recordati S.a., a reputable chemical and pharmaceutical company, where he has been instrumental in various research initiatives. His work has helped advance the development of innovative treatments that address pressing health issues.

Collaborations

Cazzulani has collaborated with notable colleagues, including Dante Nardi and Alberto Tajana. Together, they have shared insights and contributed to pioneering research that pushes the boundaries of pharmaceutical innovations.

Conclusion

Pietro Cazzulani stands as a remarkable figure in the world of invention, with his patents exemplifying his commitment to improving healthcare through innovative solutions. His work continues to influence the pharmaceutical industry and holds promise for addressing critical medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…